CareDx, Inc (NASDAQ:CDNA) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET
Company Participants
Greg Chodaczek - Managing Director
John Hanna - President and Chief Executive Officer
Abhishek Jain - Chief Financial Officer
Conference Call Participants
Bill Bonello - Craig-Hallum
Mark Massaro - BTIG
Brandon Couillard - Wells Fargo
Yi Chen - H.C. Wainwright
Mason Carrico - Stephens Inc
Thomas DeBourcy - Nephron Research
Operator
Good day, everyone, and welcome to today's CareDx, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. Please note today's call will be recorded and I will be standing by should you need any assistance.
It is now my pleasure to turn the conference over to Greg Chodaczek, Managing Director. Please go ahead, sir.
Greg Chodaczek
Thank you, Chloe, and good afternoon. Thank you for joining us today. Earlier today, CareDx released financial results for the quarter ending September 30, 2024. The release is currently available on the company's website at www.caredx.com.
John Hanna, President and Chief Executive Officer; and Abhishek Jain, Chief Financial Officer will host this afternoon's call.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of the Federal Securities Laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements.
All forward-looking statements, including without limitation, our examination of historical operating trends, expectations regarding coverage decisions, pricing, and enrollment matters, and of our financial expectations and results are based upon current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements.
Accordingly, you should not place undue reliance on these statements. For a list and descriptions of the risks and uncertainties associated with our business, please see our filings with the Securities and Exchange Commission. The information provided in this conference call speaks only to the live broadcast today, November 4, 2024.
CareDx disclaims any intention or obligation, except required by law to update or revise any information, financial projections, or other forward-looking statements, whether because of new information, future events, or otherwise. This call will also include a discussion of certain financial measures that are not calculated in accordance with Generally Accepted Accounting Principles. Reconciliation to the most direct comparable GAAP financial measure may be found in today's earnings release filed with the SEC.